Study Reveals Foster Children 4x More Likely to Get Psychotropic Drugs Than Non-Foster Children
Study Reveals Foster Children 4x More Likely to Get Psychotropic Drugs Than Non-Foster Children
Source: kalkinemedia.com
📰 Boxed Warning News
Page 22 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
Talvey Gets Accelerated Approval for Myeloma Treatment
The FDA granted an accelerated approval for Talvey to treat patients with relapsed/refractory multiple myeloma.
United States San Francisco Michael Andreini University Of California Myeloma Research Foundation Myeloma Program
Source: curetoday.com
U.S. FDA Approves TALVEY™ (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...
Source: prnewswire.com
FDA Grants Accelerated Approval to Talquetamab-tgvs for Patients With Heavily Pretreated Multiple Myeloma
Talquetamab-tgvs (Talvey) is a first-in-class bispecific antibody that binds to GPRC5D and CD3 to induce T cell-mediated killing of GPRC5D-expressing multiple myeloma cells.
United States San Francisco Michael Andreini Janssen Pharmaceutical Companies Of Johnson University Of California Myeloma Program
Source: pharmacytimes.com
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
– LINZESS EUTRx prescription demand growth increased 9% year-over-year; LINZESS U.S. net sales of $270 million, an increase of 9% year-over-year – – Expands clinical utility of LINZESS with...
United States Tom Mccourt Acquisition Of Vectivbio Holding Ag Pharmaceuticals Development Company Inc Abbvie Inc Ironwood Pharmaceuticals Nasdaq
Source: marketscreener.com
FDA Approves Zurzuvae, an Oral Treatment for Postpartum Depression
The FDA has approved Zurzuvae (zuranolone) for the treatment of postpartum depression in adults.
Christophera Viehbacher Tiffanyr Farchione Biogen Inc Division Of Psychiatry Drug Enforcement Administration Drug Administration
Source: empr.com
Vigabatrin Now Available in Tablet Form for Refractory CPS, Infantile Spasms
Vigadrone (vigabatrin), an AB-rated generic version of Sabril, is now available as a 500mg tablet in addition to the powder for oral solution formulation.
Source: neurologyadvisor.com
DEA, FDA on Adderall Shortage: Urge Drugmakers to Boost Production
The DEA and FDA addressed the Adderall shortage, urging drugmakers to boost production of stimulants and providers to develop alternative ADHD treatments.
Source: additudemag.com
Vigadrone Now Available in Tablet Form for Refractory CPS, Infantile Spasms
Vigadrone (vigabatrin), an AB-rated generic version of Sabril, is now available as a 500mg tablet in addition to the powder for oral solution formulation.
Source: empr.com
European Commission Approves Gilead's Trodelvy® For Pre-Treated HR+/HER2- Metastatic Breast Cancer
-- Approval Based on Clinically Meaningful Overall Survival Benefit Demonstrated in the TROPiCS-02 Study in Pre-Treated HR+/HER2- Metastatic Breast Cancer vs. Physician’s Choice of Chemotherapy...
United States Foster City Comunidad Autonoma De Cataluna Javier Cortes Eva Schumacher Wulf Global Health Status Quality Of Life
Source: marketscreener.com